Effects of PGI2 and analogues (taprostene, iloprost) on oxidation of native and glycated LDL (Q73035337)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Effects of PGI2 and analogues (taprostene, iloprost) on oxidation of native and glycated LDL (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

G Sobal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Sinzinger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1237-1246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

The scavenging of hydroxyl radical(.OH) by a prostacyclin analogue, taprostene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Effects of taprostene, a stable prostacyclin analogue, on haemodynamics, platelet function and arachidonate metabolism in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Effects of prostacyclin analogs on cyclic adenosine monophosphate and superoxide formation in human polymorphonuclear leukocytes stimulated by formyl-methionyl-leucyl-phenylalanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Pharmacokinetics and pharmacodynamics of radio-labeled iloprost in elderly volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Continuous monitoring of in vitro oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Lactoperoxidase-catalyzed lipid peroxidation of microsomal and artificial membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

The vitamin C treatment of allergy and the normally unprimed state of antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

The role of oxidative stress in the long-term glycation of LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

Vascular prostacyclin may be reduced in diabetes in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900359-8

10.1016/S0024-3205(99)00359-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10503939%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference